COMPREHENSIVE ASSESSMENT OF FACTORS ASSOCIATED WITH THE PROGRESSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Open Access
- 7 September 2026
- journal article
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 30 (2) , 36-44
Abstract
Introduction. The significant clinical heterogeneity of chronic obstructive pulmonary disease (COPD) manifests itself in various phenotypes, rates of progression, and responses to treatment. Since the clinical course of COPD is multifactorial, it is necessary to consider not only spirometry parameters but also clinical, laboratory, and comorbid factors when predicting disease progression. Aim - to identify patterns of changes in pulmonary function and blood oxygenation parameters in patients with COPD depending on disease stage and clinical and epidemiological characteristics. Materials and Methods. The study included 100 patients with COPD who were receiving inpatient or outpatient care at the Ternopil Regional Clinical Hospital. The diagnosis of COPD was established in accordance with the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2024) based on clinical manifestations, medical history, and spirometry results. All patients were divided into four groups based on the severity of bronchial obstruction according to the GOLD classification: Group 1—Stage I (GOLD 1)—29 patients; Group 2—Stage II (GOLD 2)—39 patients; Group 3 – Stage III (GOLD 3) – 24 patients; Group 4 – Stage IV (GOLD 4) – 8 patients. The study analyzed the demographic, clinical, and anthropometric characteristics of the patients. Statistical analysis was performed using Statistica 13.0. Results. A decrease in the FEV₁ value was observed, from 90.66±5.56% in Stage I to 23.13±4.26% in Stage IV COPD (p 0.05). COPD severity is significantly associated with increased smoking history (r = 0.53; p < 0.001) and a decrease in pulmonary function parameters (FEV₁: r = −0.95; p < 0.001) and blood oxygenation (SpO₂: r = −0.71; p < 0.001). Tobacco exposure correlates negatively with FEV₁ (r = −0.54; p < 0.001) and SpO₂ (r = −0.44; p < 0.001), whereas a strong positive correlation was found between FEV₁ and SpO₂ (r = 0.67; p < 0.001). Conclusions. The most informative approach in COPD is a comprehensive evaluation of patients that takes into account functional parameters (FEV₁, SpO₂), tobacco exposure, laboratory markers of systemic inflammation, and other clinical parameters, which allows for a more accurate assessment of COPD severity, prediction of disease progression, and optimization of treatment strategies.Keywords
This publication has 18 references indexed in Scilit:
- GOLD COPD report: 2025 updateThe Lancet Respiratory Medicine, 2024
- The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)American Journal of Respiratory and Critical Care Medicine, 2024
- Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)Advances in Therapy, 2024
- Dying with dementia in nursing homes: A population‐based study of decedents and their familiesJournal of the American Geriatrics Society, 2024
- Global Burden of Chronic Obstructive Pulmonary Disease Through 2050JAMA Network Open, 2023
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive SummaryEuropean Respiratory Journal, 2023
- Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary DiseaseJAMA, 2013
- Systemic manifestations and comorbidities of COPDEuropean Respiratory Journal, 2009
- Global burden of COPD: systematic review and meta-analysisEuropean Respiratory Journal, 2006
- Outcomes and markers in the assessment of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2006